Brain reactivity to specific symptom provocation indicates prospective therapeutic outcome in OCD

Psychiatry Research - Neuroimaging

Volumn 124, Issue 2, 2003, Pages 87-103

  Hendler, Talma ^a,b,c   Goshen, Elinor ^a,b   Zwas, S Tzila ^a,b   Sasson, Yehuda ^a,b   Gal, Gilad ^a   Zohar, Joseph ^a,b  

^a SHEBA MEDICAL CENTER   (Israel)

^b TEL AVIV UNIVERSITY   (Israel)

^c TEL AVIV SOURASKY MEDICAL CENTER   (Israel)

Author keywords

Brain circuit in OCD; Sertraline; Single photon emission computed tomography (SPECT); SSRI; Symptomatic challenge

Indexed keywords

MARKER; SEROTONIN UPTAKE INHIBITOR; SERTRALINE;

ADULT; ARTICLE; BRAIN FUNCTION; BRAIN PERFUSION; CAUDATE NUCLEUS; CINGULATE GYRUS; CLINICAL ARTICLE; CONTROLLED STUDY; FEMALE; HUMAN; MALE; NEUROIMAGING; OBSESSIVE COMPULSIVE DISORDER; PREFRONTAL CORTEX; PRIORITY JOURNAL; PROSPECTIVE STUDY; PROVOCATION TEST; SINGLE PHOTON EMISSION COMPUTER TOMOGRAPHY; STIMULUS RESPONSE; SYMPTOM; TEMPORAL CORTEX;

ADULT; AROUSAL; CAUDATE NUCLEUS; CEREBRAL CORTEX; CUES; DOSE-RESPONSE RELATIONSHIP, DRUG; DRUG ADMINISTRATION SCHEDULE; FEMALE; GYRUS CINGULI; HUMANS; MALE; MIDDLE AGED; OBSESSIVE-COMPULSIVE DISORDER; PERSONALITY INVENTORY; PROGNOSIS; REGIONAL BLOOD FLOW; SEROTONIN UPTAKE INHIBITORS; SERTRALINE; TOMOGRAPHY, EMISSION-COMPUTED, SINGLE-PHOTON; TREATMENT OUTCOME;

EID: 1642365819     PISSN: 09254927     EISSN: None     Source Type: Journal    
DOI: 10.1016/S0925-4927(03)00091-X     Document Type: Article

References (60)

1. Adler C.M., McDonough-Ryan P., Sax K.W., Holland S.K., Arndt S., Strakowski S.M. fMRI of neuronal activation with symptom provocation in unmedicated patients with obsessive compulsive disorder. Journal of Psychiatric Research. 34:2000;317-324.
2. Amunts K., Schleicher A., Burgel U., Mohlberg H., Uylings H.B., Zilles K. Broca's region revisited: cytoarchitecture and intersubject variability. Journal of Comparative Neurology. 412:1999;319-341.
3. Azari N.A., Pietrini P., Horwitz B., Pettigrew K.D. Individual differences in cerebral metabolic patterns during pharmacotherapy in obsessive-compulsive disorder: a multiple regression/discriminant analysis of positron emission tomographic data. Biological Psychiatry. 34:1993;798-809.
4. Baxter L.R. Jr. Neuroimaging studies of obsessive-compulsive disorder. Psychiatric Clinics of North America. 15:1992;871-884.
5. Baxter L.R., Schwartz J.M., Bergman K.S., Szuba M.P., Guze B.H., Mazziotta J.C., Alazraki A., Selin C.E., Ferng H.-K., Munford P., Phelps M.E. Caudate glucose metabolic rate changes with both drug and behavior therapy for OCD. Archives of General Psychiatry. 49:1992;681-689.
6. Benkelfat C., Nordahl T.E., Semple W.E., King A.C., Murphy D.L., Cohen R.M. Local cerebral glucose metabolic rates in OCD: patients treated with clomipramine. Archives of General Psychiatry. 47:1990;840-848.
7. Bonne O., Krausz Y., Shapira B., Bocher M., Karger H., Gorfine M., Chisin R., Lerer B. Increased cerebral blood flow in depressed patients responding to electroconvulsive therapy. Journal of Nuclear Medicine. 37:1996;1075-1080.
8. Breiter H.C., Rauch S.L., Kwong K.K., Baker J.R., Weisskoff R.M., Kennedy D.N., Kendrick A.D., Davis T.L., Jiang A., Cohen M.S., Stern C.E., Belliveau J.W., Baer L., O'Sullivan R.L., Savage C.R., Jenike M.A., Rosen B.R. Functional magnetic resonance imaging of symptom provocation in obsessive-compulsive disorder. Archives of General Psychiatry. 53:1996;595-606.
9. Brody A.L., Saxena S., Schwartz J.M., Stoessel P.W., Maidment K., Phelps M.E., Baxter L.R. Jr. FDG-PET predictors of response to behavioral therapy and pharmacotherapy in obsessive-compulsive disorder. Psychiatry Research. 84:1998;1-6.
10. Brody A.L., Saxena S., Silverman D.H.S., Alborzian S., Fairbanks L.A., Phelps M.E., Huang S.-C., Wu H.-M., Maidment K., Baxter L.R. Jr. Brain metabolic changes in major depressive disorder from pre- to post-treatment with paroxetine. Psychiatry Research: Neuroimaging. 91:1999;127-139.
11. Devinsky O., Morrell M.J., Vogt B.A. Contributions of anterior cingulate cortex to behaviour. Brain. 118:(Pt. 1):1995;279-306.
12. Di Chiara G., Morelli M., Consolo S. Modulatory functions of neurotransmitters in the striatum: ACh/dopamine/NMDA interactions. Trends in Neuroscience. 17:1994;228-233.
13. Elben F., Graybiel A.M. Highly restricted origin of prefrontal cortical inputs to striosomes in the macaque monkey. Journal of Neuroscience. 17:1995;1804-1814.
14. Grados M., Scahill L., Riddle M.A. Pharmacotherapy in children and adolescents with obsessive-compulsive disorder. Child and Adolescent Psychiatric Clinics of North America. 8:1999;617-634.
15. Graybiel A.M. Neurotransmitter and neuromodulators in the basal ganglia. Trends in Neuroscience. 13:1990;244-254.
16. Graybiel A.M., Rauch S.L. Toward a neurobiology of obsessive compulsive disorder. Neuron. 28:2000;343-347.
17. Hendler T., Goshen E., Tadmor R., Lustig M., Zwas S.T., Zohar J. Evidence for striatal modulation in the presence of fixed cortical injury in obsessive-compulsive disorder (OCD). European Neuropsychopharmacology. 9:1999;371-376.
18. Hoehn-Saric R., Benkelfat C. Structural and functional brain imaging in OCD. Hollander E., Zohar J., Marazziti D., Oliver B. Current Concepts in Obsessive-Compulsive Disorder. 1994;183-211 John Wiley and Sons, New York.
19. Hoehn-Saric R., McLeod D.R., Hipsley P. Is hyperarousal essential to obsessive-compulsive disorder? Diminished physiologic flexibility, but not hyperarousal, characterizes patients with obsessive-compulsive disorder. Archives of General Psychiatry. 52:1995;688-693.
20. Hoehn-Saric R., Schlaepfer T.E., Greenberg B.D., McLeod D.R., Pearlson G.D., Wong S.H. Cerebral flow in obsessive-compulsive patients with major depression: effect of treatment with sertraline or desipramine on treatment responders and non-responders. Psychiatry Research: Neuroimaging. 108:2001;89-100.
21. Holcomb H.H., Cascella N.G., Thaker G.K. Functional sites of neuroleptic drug action in the human brain: PET/FDG studies with and without haloperidol. American Journal of Psychiatry. 153:1996;41-49.
22. Insel T.R. Toward a neuroanatomy of OCD. Archives of General Psychiatry. 49:1992;739-744.
23. Kennedy S.H., Evans K.R., Kruger S., Mayberg H.S., Meyer J.H., McCann S., Arifuzzman A.I., Houle S., Vaccarino F.J. Changes in regional brain glucose metabolism measured with positron emission tomography after paroxetine treatment of major depression. American Journal of Psychiatry. 158:(6):2001;899-905.
24. Kim S.W., Dysken M.W., Kushner M.G., Kuskowski M.A., Hoover K.M., Klein K.W., Faris P.L., Hartman B.K. Phenomenological and pharmacological study of provoked obsessive/anxiety symptoms in obsessive-compulsive disorder: a preliminary study. Biological Psychiatry. 42:1997;969-975.
25. Kitayama I., Yaga T., Kayahara T., Nakano K., Murase S., Otani M., Nomura J. Long-term stress degenerates, but imipramine regenerates, noradrenergic axons in the rat cerebral cortex. Biological Psychiatry. 42:1997;687-696.
26. Lawrie S.M., Ingle G.T., Santosh C.G., Rogers A.C., Rimmington J.E., Naidu K.P., Best J.J.K., O'Carroll R.E., Goodwin G.M., Ebmeier K.P., Johnstone E.C. Magnetic resonance imaging and single photon emission tomography in treatment-responsive and treatment-resistant schizophrenia. British Journal of Psychiatry. 167:1995;202-210.
27. Leuchter A.F., Cook I.A., Uijtdehaage S.H.J., Dunkin J., Lufkin R.B., Anderson-Hanley C., Abrams M., Rosenberg-Thompson S., O-Hara R., Simon S.L., Osato S., Babaie A. Brain structure and function and the outcomes of treatment for depression. Journal of Clinical Psychiatry. 58:(Suppl. 16):1997;22-31.
28. Liotti M., Mayberg H.S., McGinnis S., Brannan S., Jerabek P. Unmasking disease-specific cerebral blood flow abnormalities: mood challenge in patients with remitted unipolar depression. American Journal of Psychiatry. 159:(1):2002;1830-1840.
29. Mayberg H.S., Liotti M., Brannan S.K., McGinnis S., Roderick B.S., Mahurin K., Jerabek P.A., Silva J.A., Tekell J.L., Martin C.C., Lancaster J.L., Fox P.T. Reciprocal limbic-cortical function and negative mood: converging PET findings in depression and normal sadness. American Journal of Psychiatry. 156:(5):1999;675-682.
30. McDougle C.J., Goodman W.K., Leckman J.F., Lee N.C., Heninger G.R., Price L.H. Haloperidol addition in fluvoxamine-refractory obsessive-compulsive disorder. A double-blind, placebo-controlled study in patients with and without tics. Archives of General Psychiatry. 51:1994;302-308.
31. McDougle C.J., Epperson C.N., Pelton G.H., Wasylink S., Price L.H. A double-blind, placebo-controlled study of risperidone addition in serotonin reuptake inhibitor-refractory obsessive-compulsive disorder. Archives of General Psychiatry. 57:2000;794-801.
32. McEwen B.S., Sapolsky R.M. Stress and cognitive function. Current Opinion in Neurobiology. 5:1995;205-216.
33. Miller F.G., Rosenstein D.L. Psychiatric symptom provoking studies: an ethical appraisal. Biological Psychiatry. 42:2000;403-409.
34. Molina V., Montz R., Martin-Loeches M., Jimenez-Vicioso A., Carreras J.L., Rubia F.J. Drug therapy and cerebral perfusion in obsessive-compulsive disorder. Journal of Nuclear Medicine. 36:1995;2234-2239.
35. Montgomery S.A. Long-term management of obsessive-compulsive disorder. International Clinical Psychopharmacology. 11:(Suppl. 5):1996;23-29.
36. Perani D., Colombo C., Bressi S., Bonfanti A. FDG PET study in obsessive-compulsive disorder: a clinical/metabolic correlation study after treatment. British Journal of Psychiatry. 1995;244-250.
37. Petrides M., Alivisatos B., Frey S. Differential activation of the human orbital, mid-ventrolateral and mid-dorsolateral prefrontal cortex during the processing of visual stimuli. Proceedings of the National Academy of Sciences USA. 99:(8):2002;5649-5654.
38. Rauch S.L., Jenike M.A., Alpert N.M., Baer L., Breiter H.C., Savage C.R., Fischman A.J. Regional cerebral blood flow measured during symptom provocation in obsessive-compulsive disorder using oxygen 15-labeled carbon dioxide and positron emission tomography. Archives of General Psychiatry. 51:1994;62-70.
39. Rauch S.L., Savage C.R., Alpert N.M., Fischman A.J., Jenike M.A. The functional neuroanatomy of anxiety: a study of three disorders using positron emission tomography and symptom provocation. Biological Psychiatry. 42:1997;446-452.
40. Rauch S.L., Benkelfat C., Dager B.S.R., Greenberg B.D., Hendler T., Hollander E., Laruelle M., Rosenberg D.R., Saxena S., Zohar J., Baxter L.R. Neuroimaging research and neurocircuitry models of obsessive compulsive disorder. International Journal of Neuropsychiatric Medicine (CNS Spectrum, Suppl. 3). 4:(5):1999;25-33.
41. Rauch S.L. Neuroimaging research and the neurobiology of obsessive-compulsive disorder: where do we go from here? Biological Psychiatry. 47:2000;168-170.
42. Rauch S.L., Shin L.M., Dougherty D.D., Alpert N.M., Fischman A.J., Jenike M.A. Predictors of fluvoxamine response in contamination-related obsessive compulsive disorder: a PET symptom provocation study. Neuropsychopharmaclogy. 27:(5):2002;782-791.
43. Robinson D., Wu H., Munne R.A., Ashtari M., Alvir J.M.J., Lerner G., Koreen A., Cole K., Bogerts B. Reduced caudate nucleus volume in obsessive-compulsive disorder. Archives of General Psychiatry. 52:1995;393-398.
44. Rosenberg D.R., Keshavan M.S., O'Hearn K.M., Dick E.L., Bagwell W.W., Seymour A.B., Montrose D.M., Pierri J.N., Birmaker. Frontostriatal measurement in treatment-naive children with obsessive-compulsive disorder. Archives of General Psychiatry. 54:1997;824-830.
45. Rosenberg D.R., Hanna G.L. Genetic and imaging strategies in obsessive-compulsive disorder: potential implications for treatment development. Biological Psychiatry. 48:2000;1210-1222.
46. Sapolsky R.M. Why stress is bad for your brain. Science. 273:1996;749-750.
47. Sasson Y., Zohar J. New developments in obsessive-compulsive disorder research: implications for clinical management. International Clinical Psychopharmacology. 11:1996;3-12.
48. Saxena S., Brody A.L., Schwartz J.M., Baxter L.R. Neuroimaging and frontal-subcortical circuitry in obsessive-compulsive disorder. British Journal of Psychiatry. 173:1998;26-38.
49. Saxena S., Brody A.L., Maidment K.M., Dunkin J.J., Colgan M., Alborzian S., Phelps M.E., Baxter L.E. Jr. Localized orbitofrontal and subcortical metabolic changes and predictors of response to paroxetine treatment in obsessive-compulsive disorder. Neuropsychopharmacology. 21:1999;683-693.
50. Saxena S., Rauch S.L. Functional neuroimaging and the neuroanatomy of obsessive-compulsive disorder. Psychiatric Clinics of North America. 23:2000;563-586.
51. Schwartz J.M., Stoessel P.W., Baxter L.R., Martin K.M. Systematic changes in cerebral glucose metabolic rate after successful behavior modification treatment of obsessive-compulsive disorder. Archives of General Psychiatry. 53:1996;109-113.
52. Swedo S.E., Schapiro M.B., Grady C.L., Cheslow D.L., Leonard H.L., Kumar A., Friedland R., Rapoport S.L., Rapoport J.L. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder. Archives of General Psychiatry. 46:1989;518-523.
53. Swedo S.E., Pietrini P., Leonard H.L., Schapiro M.B., Rettew D.C., Goldberger E.L., Rapoport S.I., Rapoport J.L., Grady C.L. Cerebral glucose metabolism in childhood-onset obsessive-compulsive disorder - revisualization during pharmacotherapy. Archives of General Psychiatry. 49:1992;690-694.
54. Szeszko P.R., Robinson D., Alvir J.M.J., Bilder R.M., Lencz T., Ashtari M., Wu H., Bogerts B. Orbital frontal and amygdala volume reductions in obsessive-compulsive disorder. Archives of General Psychiatry. 56:1999;913-919.
55. Talairach J., Tournoux P. Co-planar Stereotactic Atlas of the Human Brain. 1988;Thieme Medical Publishers, New York.
56. Tollefson G.D., Birkett M., Koran L., Genduso L. Continuation treatment of OCD: double blind and open label experience with fluvoxamine. Journal of Clinical Psychiatry. 55:(Suppl. 10):1994;69-76.
57. Vogt B.A., Finch D.M., Olson C.R. Functional heterogeneity in cingulate cortex: the anterior executive and posterior evaluative regions. Cerebral Cortex. 2:1992;435-443.
58. Vogt B.A., Nimchinsky E.A., Vogt L.J., Hof P.R. Human cingulate cortex: surface features, flat maps and cytoarchitecture. Journal of Comparative Neurology. 359:1995;490-506.
59. Woods R.P., Cherry S.R., Mazziotta J.C. Rapid automated algorithm for aligning and reslicing PET images. Journal of Computer Assisted Tomography. 16:1992;620-633.
60. Zohar J., Insel T.R., Berman K.F. Anxiety and cerebral blood flow during behavioral challenge. Archives of General Psychiatry. 46:1989;505-510.